GlassScriptPhysician profile
Craig V Adams
NPI 1114969011
$9,432.06
in general payments reported to CMS, 2019-2025
39 companies · $1,337 in 2025
The $1,337 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $627 · 2020: $403 · 2021: $14.34 · 2022: $863 · 2023: $845 · 2024: $5,344 · 2025: $1,337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,260 · Travel and Lodging: $3,265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,259.92 |
| Travel and Lodging | $3,265.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $2,374.60 | 2019-2024 | Impella |
| Philips North America LLC | $2,374.08 | 2020-2025 | (Bs2) Lm Undivided, (9520) Igt Devices Undivided, (Am5) Lead Management |
| Medtronic, INC. | $1,140.32 | 2022-2025 | Symplicity G3, Onyx Frontier, Endurant Iis |
| Atricure, INC. | $872.47 | 2022-2025 | Atriclip Laa Exclusion System, Isolator Surgical Ablation System, Atricure Cryoice Cryosphere Cryoablation System |
| Abbott Laboratories | $543.06 | 2019-2023 | Gallant |
| Ethicon US, LLC | $341.34 | 2025 | Harmonic |
| Baxter Healthcare | $219.42 | 2020-2025 | Coseal, Tisseel |
| Novartis Pharmaceuticals Corporation | $167.40 | 2019-2020 | |
| Davol INC. | $153.93 | 2023 | Progel Applicator Spray Tips |
| Chiesi USA, INC. | $134.61 | 2022-2024 | Kengreal, Cleviprex |
| Idorsia Pharmaceuticals US INC | $108.16 | 2025 | Tryvio |
| Edwards Lifesciences Corporation | $103.85 | 2019-2025 | Sapien 3 Ultra Resilia |
| Astellas Pharma US INC | $89.40 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $81.01 | 2022-2024 | Verquvo, Keytruda |
| Zimmer Biomet Holdings, INC. | $58.14 | 2024 | Sternalock |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.